Connection

Jean Nappi to Male

Back to Details
This is a "connection" page, showing publications Jean Nappi has written about Male.
Jean Nappi
Connection Strength
0.112
Male
  1. Barriers to clopidogrel adherence following placement of drug-eluting stents. Ann Pharmacother. 2009 Feb; 43(2):259-67.
    View in: PubMed
    Score: 0.017
  2. Prevalence of anemia in clinic patients with heart failure and cost analysis of epoetin treatment. Pharmacotherapy. 2007 May; 27(5):707-14.
    View in: PubMed
    Score: 0.015
  3. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia. Pharmacotherapy. 2006 Apr; 26(4):461-8.
    View in: PubMed
    Score: 0.014
  4. Role of race in the pharmacotherapy of heart failure. Ann Pharmacother. 2002 Mar; 36(3):471-8.
    View in: PubMed
    Score: 0.011
  5. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines. Ann Pharmacother. 2001 May; 35(5):589-617.
    View in: PubMed
    Score: 0.010
  6. Myocardial infarction in women: a critical appraisal of gender differences in outcomes. Pharmacotherapy. 2000 Sep; 20(9):1034-44.
    View in: PubMed
    Score: 0.010
  7. Pharmacy residency training measured through a standardized knowledge test. Am J Health Syst Pharm. 2016 Dec 15; 73(24):2095-2098.
    View in: PubMed
    Score: 0.007
  8. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial. Antimicrob Agents Chemother. 2011 Dec; 55(12):5475-9.
    View in: PubMed
    Score: 0.005
  9. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. J Card Fail. 2010 Mar; 16(3):188-93.
    View in: PubMed
    Score: 0.005
  10. Initial and long-term outpatient experience with pirmenol for control of ventricular arrhythmias. Eur J Clin Pharmacol. 1986; 31(1):15-22.
    View in: PubMed
    Score: 0.003
  11. Pirmenol for control of ventricular arrhythmias: oral dose-ranging and short-term maintenance study. Am J Cardiol. 1984 Feb 01; 53(4):522-7.
    View in: PubMed
    Score: 0.003
  12. Efficacy of intravenous pirmenol hydrochloride for treatment of ventricular arrhythmias: a controlled comparison with lidocaine. J Cardiovasc Pharmacol. 1983 Mar-Apr; 5(2):213-20.
    View in: PubMed
    Score: 0.003
  13. Combination antiplatelet therapy: implications for pharmacists. J Am Pharm Assoc (Wash). 2002 Nov-Dec; 42(6):880-3.
    View in: PubMed
    Score: 0.003
  14. Antihypertensive monotherapy with tablet (prompt-release) diltiazem: multicenter controlled trials. Cardiovasc Drugs Ther. 1990 Aug; 4(4):1089-96.
    View in: PubMed
    Score: 0.001
  15. Sustained-release diltiazem: duration of antihypertensive effect. J Clin Pharmacol. 1989 Jun; 29(6):533-7.
    View in: PubMed
    Score: 0.001
  16. Metabolic effects of antihypertensive therapy with a calcium antagonist. Am J Cardiol. 1988 Oct 05; 62(11):109G-113G.
    View in: PubMed
    Score: 0.001
  17. The disposition of recainam hydrochloride during and after intravenous loading and maintenance infusion in cardiac patients. J Clin Pharmacol. 1987 Dec; 27(12):951-6.
    View in: PubMed
    Score: 0.001
  18. Individualization of phenytoin dosage regimens. Clin Pharmacol Ther. 1977 Mar; 21(3):287-93.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.